Clinical Trials Market Intelligence Report - Global Forecast to 2027

Clinical Trials Market Intelligence Report - Global Forecast to 2027

The Global Clinical Trials Market is projected to reach USD 54,306.00 million by 2027 from USD 32,276.86 million in 2021, at a CAGR 9.05% during the forecast period.

Market Statistics:

The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

• The Americas Clinical Trials Market size was estimated at USD 11,212.70 million in 2021 and expected to reach USD 12,148.43 million in 2022, at a CAGR 8.88% to reach USD 18,682.89 million by 2027.
• The Asia-Pacific Clinical Trials Market size was estimated at USD 9,435.87 million in 2021 and expected to reach USD 10,351.97 million in 2022, at a CAGR 9.32% to reach USD 16,113.67 million by 2027.
• The Europe, Middle East & Africa Clinical Trials Market size was estimated at USD 11,628.29 million in 2021 and expected to reach USD 12,642.77 million in 2022, at a CAGR 9.00% to reach USD 19,509.43 million by 2027.

Market Segmentation & Coverage:

The report on clinical trials identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. Our market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for your market plan.

This research report categorizes the clinical trials to forecast the revenues and analyze the trends in each of the following sub-markets:

Design:

• Interventional Study
  • Adaptive Clinical Trial
  • Non-randomized Control Trial
  • Randomized Control Trial
• Observational Study
  • Case Control Study
  • Cohort Study
  • Cross Sectional Study
  • Ecological Study

Phase:

• Phase I
• Phase II
• Phase III
• Phase IV

Indication:

• Autoimmune/Inflammation
• Cardiovascular
• CNS condition
• Diabetes
• Infectious Diseases
• Obesity
• Oncology
• Pain management

Region:

• Americas
  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
    • California
    • Florida
    • Illinois
    • New York
    • Ohio
    • Pennsylvania
    • Texas
• Asia-Pacific
  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
• Europe, Middle East & Africa
  • France
  • Germany
  • Italy
  • Netherlands
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • United Arab Emirates
  • United Kingdom

Company Usability Profiles:

• Accell Clinical Research, LLC
• Atlant Clinical Ltd.
• Charles River Laboratories International, Inc.
• Clinipace
• Eli Lilly and Company
• Icon PLC
• IQVIA Holdings, Inc.
• Novo Nordisk A/S
• Parexel International Corporation
• Pfizer Inc.
• ProPharma Group Holdings, LLC
• SGS S.A.
• SIRO Clinpharm Private Limited
• Syneos Health, Inc.
• Thermo Fisher Scientific Inc.
• Wuxi AppTec Inc.

Currency: USD

Base Year: 2021

Estimated Year: 2022

Forecast Year: 2027

Base Year Value: USD 32,276.86 million

Estimated Year Value: USD 35,143.18 million

Forecast Year Value: USD 54,306.00 million

CAGR (%): 9.05%.

Please Note: PDF & Excel + Online Access - 1 Year